ORYZON continues to strengthen its patent portfolio for vafidemstat 22/04/2025 Healthcare Innovative drugs Oryzon secures new patents in Europe and Japan for vafidemstat, extending protection until 2040 for ADHD and autism... Partners - Oryzon Genomics
ORYZON announces first patient dosed in NCI-sponsored Phase I/II clinical trial of iadadem... 15/04/2025 Healthcare Innovative drugs Oryzon Genomics has launched a clinical trial in the U.S. to evaluate for the first time the combination of its... Partners - Oryzon Genomics
Telum Therapeutics, Complutense University of Madrid and Carlos III Health Institute disco... 03/04/2025 Healthcare Innovative drugs It was funded by Spanish Ministry of Science, Innovation and Universities (MCIN) and the European Union through the... Partners - TELUM THERAPEUTICS
SpliceBio advances SB-007 gene therapy with the first patient dosed in the ASTRA phase 1/2... 02/04/2025 Healthcare Innovative drugs It is the most common form of juvenile macular degeneration, leading to progressive central vision loss and ultimately... Partners - Parc Científic de Barcelona
LIVERtera: Revolutionizing Cancer Research with In Silico Models and Liver Tumor Organoids 13/03/2025 Healthcare Innovative drugs Advanced therapies A Biotechnological Leap in the Fight Against Liver Cancer Partners - BeCytes Biotechnologies
Biotechnology Advances in the development of key therapies for kidney diseases 13/03/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies By 2040, chronic kidney disease (CKD) is projected to become the fifth leading cause of years of life lost, emphasizing... AseBio
Bionet introduces the new version of the F1 Bioreactor — your ultimate solution for versat... 06/03/2025 Healthcare Access to innovation Innovative drugs All bioprocessing requirements in one, every detail of every application meticulously addressed. Partners - Bionet Ingeniería
CONNECTA Therapeutics announces positive results from Phase I study of neurodevelopmental ... 06/03/2025 Healthcare Access to innovation Innovative drugs Advanced therapies CONNECTA Therapeutics has achieved positive results in the Phase I clinical trial of CTH120, an investigational drug... Partners - CONNECTA THERAPEUTICS
Accelerating Innovation from Discovery to Development 03/03/2025 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies Pharmaron accelerates drug discovery by transforming scientific breakthroughs into therapies, using advanced... Partners - Pharmaron
ORYZON reports financial results and corporate update for quarter ended December 31, 2024 03/03/2025 Healthcare Innovative drugs Se han realizado inversiones en I+D por importe de 8,3 M€, de las cuales 7,6 M€ corresponden a desarrollo y 0,7 M€ a... Partners - Oryzon Genomics
